Manjula Basappa

发表

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

J. Mascola, D. Douek, N. Sullivan, 2022, bioRxiv.

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

J. Mascola, G. Chuang, D. Douek, 2022, Cell.

A Monoclonal Antibody for Malaria Prevention.

J. Mascola, Zonghui Hu, A. McDermott, 2021, The New England journal of medicine.

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

Lindsay N. Carpp, Mathieu Le Gars, M. Andrasik, 2022, medRxiv.

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Lindsay N. Carpp, M. Andrasik, J. Kublin, 2022, Nature Microbiology.

Antibody Reactivity Against SARS-CoV-2 in Adults from the Vancouver Metropolitan Area, Canada

D. Douek, A. McDermott, M. Basappa, 2020, SSRN Electronic Journal.

Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 months

D. Douek, A. McDermott, S. Narpala, 2020 .

Antibody reactivity to SARS-CoV-2 in adults from the Vancouver metropolitan area, Canada.

D. Douek, A. McDermott, S. Narpala, 2020, medRxiv : the preprint server for health sciences.

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

J. Mascola, R. Koup, C. Andrews, 2023, The Lancet. Infectious diseases.